Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,243 | -8,224 | -6,421 | -4,407 | -2,174 |
| Accounts receivable | -63 | -330 | -380 | -71 | -124 |
| Other Working Capital | 167 | 132 | 1,215 | 670 | 178 |
| Other Operating Activity | 508 | 1,825 | 1,496 | 819 | 505 |
| Operating Cash Flow | $-1,631 | $-6,596 | $-4,090 | $-2,989 | $-1,615 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 7,444 | 7,444 | 7,444 | 175 |
| Other Financing Activity | 0 | -149 | -149 | -149 | -4 |
| Financing Cash Flow | $N/A | $7,295 | $7,295 | $7,295 | $172 |
| Beginning Cash Position | 9,844 | 9,145 | 9,145 | 9,145 | 9,145 |
| End Cash Position | 8,213 | 9,844 | 12,350 | 13,451 | 7,701 |
| Net Cash Flow | $-1,631 | $699 | $3,205 | $4,306 | $-1,444 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,631 | -6,596 | -4,090 | -2,989 | -1,615 |
| Free Cash Flow | -1,631 | -6,596 | -4,090 | -2,989 | -1,615 |